Denali Therapeutics to Report Third Quarter 2026 Financial Results and Business Highlights on November 3, 2026
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
| (NASDAQ: DNLI) | Delayed: 18.41 -0.25 (1.34%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $18.66 | 52 Week High | $ | |||
| Open | $18.49 | 52 Week Low | $ | |||
| Day High | $18.50 | P/E | N/A | |||
| Day Low | $18.01 | EPS | $ | |||
| Volume | 1,005,556 | |||||
